Premium
The National Company Law Appellate Tribunal (NCLAT) has set aside a lower court’s order to liquidate Sterling Biotech Ltd and allowed its lenders to withdraw insolvency proceedings against the debt-laden pharmaceutical company. The tribunal also said that the lenders can now accept the one-time debt settlement offer made on behalf of ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
